NCT02176382View on ClinicalTrials.gov

Denosumab and Teriparatide Study (DATA-HD and DATA-EX)

PHASE4CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

February 29, 2020

Study Completion Date

February 29, 2020

Conditions
Postmenopausal Osteoporosis
Interventions
DRUG

denosumab

denosumab subcutaneous injection

DRUG

teriparatide

teriparatide daily subcutaneous injection

DRUG

Zoledronic acid

zoledronic acid infusion

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT02176382 - Denosumab and Teriparatide Study (DATA-HD and DATA-EX) | Biotech Hunter | Biotech Hunter